The Neuropathology Core (Core D) of the Johns Hopkins Alzheimer's Disease Research Center (ADRC) has two overarching goals, one related to the analysis and distribution of brain tissue and other specimens from subjects in the ADRC, and the other related to the analysis of genetically engineered mouse models by investigators associated with the ADRC.
The specific aims of Core D are as follows: (1) to arrange and perform autopsies on clinically well-characterized subjects enrolled through the JHMI ADRC and assist with consensus diagnoses on subjects associated with the ADRC (comprised of the Clinic Cohort and the BLSA Cohort). (2) to accession and store optimally prepared tissues from the autopsies and to make these specimens available to investigators associated with the ADRC and at other collaborating institutions. (3) to accession and store samples of biological fluids and DNA obtained pre- and postmortem from subjects in the ADRC. (4) to facilitate APOE genotyping on participants in the ADRC. (5) to support the assessment of genetically engineered mouse models relevant to Alzheimer's disease (AD) and related disorders, (6) to collaborate with the medical and research community outside of Johns Hopkins by providing assistance with postmortem diagnoses of AD and other types of dementia, and (7) to train basic investigators and clinical neuroscientists in the morphological and diagnostic concepts relevant to AD, to other types of dementias and neurodegenerative disorders.
The Johns Hopkins Alzheimer's Disease Research Center (ADRC) will address many of the topics important to dementia research, with a particular focus on the understanding the earliest phases of Alzheimer's disease (AD). This approach is important if we are ultimately going to be able to diagnose and treat AD as early as possible. The ADRC fosters interactions among scientists who are pursuing this overarching theme.
|Gracia-Garcia, Patricia; de-la-Camara, Concepcion; Santabarbara, Javier et al. (2015) Depression and incident Alzheimer disease: the impact of disease severity. Am J Geriatr Psychiatry 23:119-29|
|Marano, Christopher M; Workman, Clifford I; Lyman, Christopher H et al. (2015) Structural imaging in late-life depression: association with mood and cognitive responses to antidepressant treatment. Am J Geriatr Psychiatry 23:12-Apr|
|Ning, Jing; Bandeen-Roche, Karen (2014) Estimation of time-dependent association for bivariate failure times in the presence of a competing risk. Biometrics 70:10-20|
|Reagh, Zachariah M; Roberts, Jared M; Ly, Maria et al. (2014) Spatial discrimination deficits as a function of mnemonic interference in aged adults with and without memory impairment. Hippocampus 24:303-14|
|Ho, Cheng-Ying; Troncoso, Juan C; Knox, David et al. (2014) Beta-amyloid, phospho-tau and alpha-synuclein deposits similar to those in the brain are not identified in the eyes of Alzheimer's and Parkinson's disease patients. Brain Pathol 24:25-32|
|Beecham, Gary W; Hamilton, Kara; Naj, Adam C et al. (2014) Genome-wide association meta-analysis of neuropathologic features of Alzheimer's disease and related dementias. PLoS Genet 10:e1004606|
|Leal, Stephanie L; Tighe, Sarah K; Jones, Craig K et al. (2014) Pattern separation of emotional information in hippocampal dentate and CA3. Hippocampus 24:1146-55|
|Ayers, Jacob I; Xu, Guilian; Pletnikova, Olga et al. (2014) Conformational specificity of the C4F6 SOD1 antibody; low frequency of reactivity in sporadic ALS cases. Acta Neuropathol Commun 2:55|
|Semba, Richard D; Moghekar, Abhay R; Hu, Jason et al. (2014) Klotho in the cerebrospinal fluid of adults with and without Alzheimer's disease. Neurosci Lett 558:37-40|
|Wendell, Carrington R; Waldstein, Shari R; Zonderman, Alan B (2014) Nonlinear longitudinal trajectories of cholesterol and neuropsychological function. Neuropsychology 28:106-12|
Showing the most recent 10 out of 320 publications